Breaking News Instant updates and real-time market news.

NOVN

Novan

$2.35 /

-0.055 (-2.29%)

08:32
10/18/19
10/18
08:32
10/18/19
08:32

Novan submits request for pre-IND meeting with FDA for SB207

Novan announced that the Company has submitted a request for a pre-IND meeting with the U.S. Food and Drug Administration for new product candidate, SB207. The Company anticipates that the meeting will be held in December 2019. Novan has identified targeted viral opportunities of high unmet need where the Company's nitric oxide releasing technology could provide clinical benefit to patients. The SB207 product incorporates the Company's existing drug substance, berdazimer sodium, with a new formulation specifically engineered and tailored to be effective within a number of viral indications. Novan also anticipates that SB207 is a product candidate well-suited for an external genital warts program. The drug substance in SB207 has previously been tested in Phase 2 clinical studies of Novan's existing product candidate for external genital warts and molluscum contagiosum. Data from these trials demonstrated that SB206 was both efficacious and well-tolerated.

NOVN Novan
$2.35 /

-0.055 (-2.29%)

03/29/19 JMP Securities
Novan downgraded to Market Perform from Outperform at JMP Securities
12/10/18 H.C. Wainwright
Novan 'highly undervalued' after 'best-case' data, says H.C. Wainwright
10/26/18
On The Fly: Top analyst initiations
10/26/18 H.C. Wainwright
Novan initiated with a Buy at H.C. Wainwright

TODAY'S FREE FLY STORIES

Downgrade
Teladoc downgraded to Sector Weight on valuation at KeyBanc » 06:10
02/28/20
02/28
06:10
02/28/20
06:10
TDOC

Teladoc

$135.17 /

+18.285 (+15.64%)

KeyBanc analyst Donald…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Upgrade
Cboe Global Markets upgraded to Neutral from Underperform at BofA » 06:10
02/28/20
02/28
06:10
02/28/20
06:10
CBOE

Cboe Global Markets

$121.38 /

-2.26 (-1.83%)

BofA analyst Michael…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Verastem says sees FY20 OpEx down approximately 40% y/y » 06:10
02/28/20
02/28
06:10
02/28/20
06:10
VSTM

Verastem

$1.90 /

-0.1 (-5.00%)

As a result of its…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Periodicals
Google, Microsoft shift production from China amid coronavirus, Nikkei reports » 06:09
02/28/20
02/28
06:09
02/28/20
06:09
GOOG

Alphabet

$1,318.90 /

-74.78 (-5.37%)

, GOOGL

Alphabet Class A

$1,314.93 /

-75.64 (-5.44%)

, MSFT

Microsoft

$158.00 /

-12.2 (-7.17%)

Google (GOOGL) and…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Verastem says primary focus will be development of CH5126766 » 06:08
02/28/20
02/28
06:08
02/28/20
06:08
VSTM

Verastem

$1.90 /

-0.1 (-5.00%)

Verastem announced a new…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Initiation
HBT Financial initiated with a Neutral at Piper Sandler » 06:08
02/28/20
02/28
06:08
02/28/20
06:08
HBT

HBT Financial

$16.76 /

-0.36 (-2.10%)

Piper Sandler analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
W.R. Grace raises share repurchase authorization to $250M » 06:06
02/28/20
02/28
06:06
02/28/20
06:06
GRA

W.R. Grace

$54.57 /

-2.13 (-3.76%)

W. R. Grace announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Upgrade
HollyFrontier upgraded to Overweight from Neutral at Piper Sandler » 06:06
02/28/20
02/28
06:06
02/28/20
06:06
HFC

HollyFrontier

$32.39 /

-3.56 (-9.90%)

, DK

Delek US

$20.38 /

-1.84 (-8.28%)

, PBF

PBF Energy

$22.57 /

-1.08 (-4.57%)

, PARR

Par Pacific

$16.92 /

-0.24 (-1.40%)

Piper Sandler analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Fennec receives EMA validation for marketing application for sodium thiosulfate » 06:05
02/28/20
02/28
06:05
02/28/20
06:05
FENC

Fennec

$6.94 /

+0.24 (+3.58%)

Fennec announced that the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

General news
Oil Action: Front-month WTI futures down another 3.7% » 06:05
02/28/20
02/28
06:05
02/28/20
06:05

Oil Action: Front-month…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Earnings
Mersana Therapeutics reports Q4 EPS (34c), consensus (38c) » 06:04
02/28/20
02/28
06:04
02/28/20
06:04
MRSN

Mersana Therapeutics

$8.69 /

-0.56 (-6.05%)

Cash, cash equivalents…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Downgrade
Valero downgraded to Neutral from Overweight at Piper Sandler » 06:03
02/28/20
02/28
06:03
02/28/20
06:03
VLO

Valero

$66.23 /

-5.48 (-7.64%)

Piper Sandler analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Downgrade
PBF Energy downgraded to Neutral from Overweight at Piper Sandler » 06:03
02/28/20
02/28
06:03
02/28/20
06:03
PBF

PBF Energy

$22.57 /

-1.08 (-4.57%)

Piper Sandler analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Upgrade
Cboe Global Markets upgraded to Neutral from Underperform at BofA » 06:02
02/28/20
02/28
06:02
02/28/20
06:02
CBOE

Cboe Global Markets

$121.38 /

-2.26 (-1.83%)

BofA upgraded Cboe Global…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
AES Corp. sees FY20 adjusted EPS $1.40 -$1.48, consensus $1.44 » 06:02
02/28/20
02/28
06:02
02/28/20
06:02
AES

AES Corp.

$18.39 /

-0.31 (-1.66%)

Reaffirming 7%-9% average…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
AES Corp. reports Q4 adjusted EPS 35c, consensus 33c » 06:01
02/28/20
02/28
06:01
02/28/20
06:01
AES

AES Corp.

$18.39 /

-0.31 (-1.66%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Tabula Rasa HealthCare price target raised to $72 from $66 at Piper Sandler » 06:00
02/28/20
02/28
06:00
02/28/20
06:00
TRHC

Tabula Rasa HealthCare

$57.02 /

-6.43 (-10.13%)

Piper Sandler analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Upgrade
Aker BP upgraded to Overweight from Equal Weight at Barclays » 05:57
02/28/20
02/28
05:57
02/28/20
05:57
DETNF

Aker BP

$0.00 /

+ (+0.00%)

Barclays analyst James…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Downgrade
Eventbrite downgraded to Sector Perform from Outperform at RBC Capital » 05:45
02/28/20
02/28
05:45
02/28/20
05:45
EB

Eventbrite

$16.98 /

-0.74 (-4.18%)

RBC Capital analyst Mark…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Moderna has five potential mRNA rare disease blockbusters, says Piper Sandler » 05:42
02/28/20
02/28
05:42
02/28/20
05:42
MRNA

Moderna

$26.16 /

-3.01 (-10.32%)

Piper Sandler analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Downgrade
Gilead downgraded to Hold from Buy at DZ Bank » 05:36
02/28/20
02/28
05:36
02/28/20
05:36
GILD

Gilead

$72.66 /

-2.04 (-2.73%)

DZ Bank analyst Elmar…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Downgrade
Nielsen downgraded to Neutral from Outperform at Baird » 05:35
02/28/20
02/28
05:35
02/28/20
05:35
NLSN

Nielsen

$18.49 /

-1.8 (-8.87%)

Baird analyst Jeffrey…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Upgrade
Intellia Therapeutics upgraded to Outperform from Perform at Oppenheimer » 05:34
02/28/20
02/28
05:34
02/28/20
05:34
NTLA

Intellia Therapeutics

$11.69 /

-0.61 (-4.96%)

Oppenheimer analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Downgrade
AB InBev downgraded to Neutral from Buy at Bryan Garnier » 05:33
02/28/20
02/28
05:33
02/28/20
05:33
BUD

AB InBev

$60.20 /

-6.15 (-9.27%)

Bryan Garnier analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Upgrade
Horizon Technology upgraded to Neutral from Sell at Compass Point » 05:31
02/28/20
02/28
05:31
02/28/20
05:31
HRZN

Horizon Technology

$11.56 /

-0.455 (-3.79%)

Compass Point analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.